VIR-7831 (sotrovimab)
VIR-7831-5001
Phase 3 mab completed
Quick answer
VIR-7831 (sotrovimab) for Covid19 is a Phase 3 program (mab) at Vir Biotechnology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vir Biotechnology
- Indication
- Covid19
- Phase
- Phase 3
- Modality
- mab
- Status
- completed